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Defectsinapical-basalpolarityregulationareassociatedwithtissueovergrowthandtumorogenesis,yetthemolecularmechanisms
linking epithelial polarity regulators to hyperplasia or neoplasia remain elusive. In addition, exploration of the expression and
function of the full complement of proteins required for the polarized architecture of epithelial cells in the context of cancer is
awaited. This paper provides an overview of recent studies performed on Drosophila and vertebrates showing that apical polarity
proteins of the Crumbs family act to repress tissue growth and epithelial to mesenchymal transition. Thus, these proteins emerge
as potential tumor suppressors. Interestingly, analysis of the molecular function of Crumbs proteins reveals a function for these
polarity regulators in junctional complexes stability and control of signaling pathways regulating proliferation and apoptosis.
Thereby, these studies provide a molecular basis explaining how regulation of epithelial polarity is coupled to tumorogenesis.
1.EpithelialPolarity
Epithelialtissuescoverthesurfaceandlineinternalcavitiesof
the human body. Simple epithelia act as a diﬀusion barrier,
generate vectorial transport, and sustain spatially oriented
secretion to subdivide the body into morphologically and
physiologically distinct compartments. The unidirectional
nature of these functions requires the asymmetric distribu-
tion of many cellular constituents, a structural organization
referred to as epithelial polarity. Epithelial polarization
results from the regionalization of the plasma membrane
into apical, lateral, and basal domains. The apical domain
faces the external environment or a lumen, the lateral
domainspansacrosstheplaneoftheepitheliumandcontacts
neighboring cells, and the basal domain is attached to the
basementmembrane(Figure 1).Apicaljunctionalcomplexes
are established at the interface between the apical and lateral
domains to maintain the cohesion and impermeability of
epithelia. Several proteins important for epithelial polarity
have been identiﬁed in recent years, mainly in model
organisms like C. elegans and Drosophila melanogaster [1].
The function of these proteins is conserved from worm to
man, reﬂecting the signiﬁcance of epithelial polarity. The
importance of the polarized architecture of epithelial cells
is further emphasized by the fact that numerous pathologies
are associated with epithelial polarity defects, including most
human cancers [2, 3].
2.Roles ofCrumbs ProteinsinEpithelial
PolarityRegulation
Epithelial polarity is organized by a complex network of
evolutionarily conserved proteins, including theapical trans-
membrane protein Crumbs (Crb) [1, 4–6]. Drosophila
embryos lacking Crb display apical-basal polarity defects in
several epithelia, which eventually collapse [5, 7]. Overex-
pression of Crb dominantly extends the apical domain at
the expense of the lateral domain [8], showing that Crb
is an important apical determinant. Mutual antagonism
between Crb and basolateral polarity modules is crucial
for segregation and size control of membrane domains in
epithelial cells, thus impacting on tissue morphogenesis [9–
13].
The human genome encodes three Crb orthologs named
CRB1, CRB2, and CRB3 [4]. CRB1 expression is restricted2 Journal of Biomedicine and Biotechnology
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Figure 1: Organization of epithelial tissues. Epithelial cells are
polarized along an apical-basal axis. The apical domain faces a
lumen or the environment, the lateral domain contacts neighboring
cells, and the basal domain is anchored to the basement membrane.
This polarized architecture sustains unidirectional functions, such
as vectorial transport. The apical and lateral domains are segregated
by the zonula adherens, which is a circumferential adherens junc-
tion maintaining intercellular adhesion within epithelial tissues.
In chordates epithelia, paracellular diﬀusion is limited by tight
junctions, which sit apical to the zonula adherens. In insect, this
sealing function is assumed by septate junctions that are established
basal to the zonula adherens.
to the brain, cornea, and retina [14–16]. Mutations in
humanCRB1ormouseCrb1 genescausedegenerativeretinal
pathologies [14, 17–19]. Similarly, loss of Crb is associated
with light-induced retinal degeneration in ﬂies [20]. CRB2
is expressed in several tissues [21], but its function remains
poorly understood. CRB3 is expressed in most epithelia and
exist as two splice variants. CRB3A is apically localized at
the level of tight junctions [4, 22] and promotes intercellular
junction formation as well as epithelial polarity [23–25].
CRB3B is associated with spindle poles in dividing cells or
found in the apical cilium of polarized kidney epithelial cells
to control cytokinesis and ciliogenesis, respectively [26].
Similar to Crb, CRB1 and CRB2 possess a large extra-
cellular domain containing EFG and laminin repeats [5, 7,
14]. In contrast, CRB3 has a short extracellular domain
showingnoclearhomologywiththeotherCrbproteins[22].
However, Drosophila Crb and the entire set of human CRB
proteins contain a highly conserved cytoplasmic tail [4, 5],
which is characterized by the presence of a FERM (4.1, ezrin,
radixin, moesin) domain-binding site that is important for
Crb function and regulation [11, 27, 28]. In addition, the
last four amino acids (ERLI) of the cytoplasmic tail of Crb,
CRB1, CRB2, and CRB3A interact with the protein Stardust
(Sdt; named PALS1 in mammals) linking Crb or human
CRB proteins to Drosophila PATJ (dPatj) or Patj, respectively
[29–31]. Mutations in sdt phenocopy crb loss-of-function
[29, 32, 33]. In addition, the ability of exogenous Crb to
rescue the crb mutant phenotype depends on the ERLI motif
[27]. PALS1 has been implicated in epithelial polarity as well
ascell-celljunctionformation[25,34].dPatjisimportantfor
Crb complex stabilization at the apical membrane, and Patj
controls the delivery of CRB3 to the apical domain as well as
tight junction formation [35–37]. These studies suggest that
Sdt/PALS1 and dPatj/Patj play crucial roles as downstream
eﬀectors and/or regulators of Crb/CRB3.
3.PolarityandCancer
Loss of cell polarity is a typical hallmark of tumor pro-
gression in epithelial tissues. The polarized architecture of
epithelial cells is compromised at early steps of epithelial
to mesenchymal transition (EMT), a process also asso-
ciated with loss of cell-cell adhesion and acquisition of
migratory and invasive properties [38]. Thus, EMT is a
critical step in carcinoma progression and metastasis. These
observations predict that regulators of apical-basal polarity
are fundamental to preserve epithelial homeostasis and to
limit tumorogenesis. This hypothesis was ﬁrst supported by
studiesinDrosophilashowingthatlossofanymembersofthe
lateral-promotingScribble(Scrib)polaritymodulepromotes
epithelial tissue overgrowth and disorganization, resulting
in a tumor-like phenotype [39]. The tumor suppressor
function of Scrib is conserved in mice [40]. These data have
inspired a number of scientists who demonstrated that the
expression of many epithelial polarity regulators is altered
in several cancers and that proteins required for epithelial
polarization are important targets of viral oncoproteins
[2, 3, 41]. Finally, mutations in the gene encoding the
polarity protein Lkb1 cause a genetic syndrome associated
with a high incidence of cancer [42]. Together, these recent
discoveries clearly established that further characterization
of proteins coordinating epithelial polarity will contribute
to our understanding of cancer biology. Deciphering the
molecular mechanisms by which polarity proteins act as
tumor suppressors is a major issue yet to be solved in this
ﬁeld of research.
3.1. CRB3 and Tumor Growth. The role of the polarity
protein CRB3 in cancer was not thoroughly studied yet, but
increasing evidence suggests that this protein could restrict
tumor progression. Gene expression proﬁling revealed that
repression of CRB3 expression correlates with increased
tumorigenic potential in mouse kidney epithelial cells. Re-
expression of CRB3 restored cell-cell junctions integrity and
cell polarization, while limiting cell motility and metastasis
[43]. This suggests that loss of CRB3 in tumor cells is not
coincidental, but plays an active role in tumorogenesis. A
mechanism leading to the loss of CRB3 expression was
recently elucidated. Indeed, CRB3 expression is repressed
by two factors promoting EMT, namely, the transcription
regulators Snail and ZEB1 [44–46]. Expression of these
proteins alters cell-cell adhesion, while increasing migration,
invasion, and metastasis [45, 47, 48]. Snail and ZEB1 directly
bind to and repress CRB3 promoter [44, 46]. Importantly,
expression of exogenous CRB3 in Snail-expressing cells
partially restores the formation of cell-cell junctions and
the epithelial phenotype, suggesting that CRB3 gene is a
functional target of Snail and that its repression contributes
to EMT [46]. Expression of Snail and ZEB1 is increased in
many human tumors, and it correlates with dediﬀerentiation
and invasion [47–49]. This suggests that CRB3 expression isJournal of Biomedicine and Biotechnology 3
reduced in human cancers allowing for tumor progression,
but a former demonstration of this hypothesis remains
awaited.Collectively,theseﬁndingsestablishthatitisofgreat
interest to study CRB3 in tumor of epithelial origin, which
accounts for the vast majority of human cancers.
3.2. Mechanisms by Which Crb Proteins Could Act as
Tumor Suppressors
3.2.1. Crb and CRB3 Activates the Tumor Suppressor Sal-
vador/Warts/Hippo Pathway. Although it is clear that alter-
ation of epithelial polarity contributes to tissue overgrowth,
mechanistic insights into how polarity regulators act in
this context are missing. Recent studies on Drosophila and
mammalian cells have shown that Crb and CRB3 regulate
signaling pathways controlling proliferation and survival,
including the Salvador/Warts/Hippo (SWH) pathway. In
Drosophila, the adaptor protein Salvador (Sav) associates
with the kinase Hippo (Hpo), which phosphorylates and
activates the kinase Warts (Wts) [50]. Activated Wts,
in association with mob as a tumor suppressor (Mats),
phosphorylates the transcriptional coactivator Yorkie (Yki).
Phospho-Yki is sequestered in the cytoplasm and unable
to activate its proproliferative (cyclin E, E2F1, and bantam)
andantiapoptotic(Drosophilainhibitorofapoptosis(diap1))
target genes [50, 51]. Thus, inhibition of the SWH pathway
leads to Yki-dependent stimulation of cell proliferation and
survival, leading to tissue hyperplasia (Figure 2)[ 51]. The
cortical FERM-domain protein Expanded (Ex) also represses
Yki-dependent transcription. Ex may act by binding directly
to Yki to limit its nuclear translocation [52]. Proper localiza-
tion at apical junctions and function of Ex depend on the
protocadherin Fat, which potentially couples extracellular
signals to Yki regulation [53–55]. The SWH pathway is
w e l lc o n s e r v e di nm a m m a l sa n dc o n t r i b u t e st oc e l lg r o w t h
regulation. Overexpression of the Yki ortholog YAP pro-
motes EMT and uncontrolled proliferation [56]. A similar
scenario prevails in vivo where YAP overexpression increases
liver size and expands progenitor cell population in the
intestinalepithelium[57,58].Basedonthesestudies,itisnot
surprising that LATS1, MOB, and SAV (the homolog of Wts,
Mats and Sav, resp.) were described as tumor suppressors
[59–62]. Thus, further deﬁning the regulation of the SWH
pathway will reﬁne our understanding of tissue growth and
organ size regulation, as well as human diseases associated
with proliferation and apoptosis deregulation such as cancer.
In particular, identiﬁcation of upstream regulators of the
SWH and determination of their mechanism of action
represent an important challenge.
Loss of crb leads to tissue hyperplasia in Drosophila larval
epithelial discs [63–65]. Reduction of Crb amount increases
organ overgrowth resulting from Yki overexpression, and a
crbnull allele enhances tissue enlargement in a hypomorphic
ex background [64, 66]. Moreover, lack of Crb increases
the expression of Yki target genes [64]. This suggests that
Crb is a positive regulator of Ex and SWH pathway and
contributes to limiting Yki activity. In the absence of Crb, Ex
protein accumulates, but is delocalized basally to its normal
location [63, 64, 66]. This suggests that Crb-dependent Ex
localization is crucial for its function. The recruitment of Ex
by Crb likely depends on a direct binding of these proteins
[63]. Whether there is collaboration between Fat and Crb to
localize Ex remains to be determined [53, 54]. Intriguingly,
overexpressionofCrborexpressionofthemembrane-bound
cytoplasmic tail of Crb (Crbintra) decreases Ex levels and
increases cell growth through Yki activation [63, 64, 66–68].
Thus, lack of Crb or excessive amount of this protein results
in a similar Yki-dependent phenotype. This could suggests
that Crb overabundance has a dominant negative eﬀect,
perhaps by disrupting stoichiometry of a Crb-containing
complex. However, the opposite eﬀect of Crbintra expression
or loss of Crb on Ex levels argues against this hypothesis and
rather suggest that Crb has a complex function within the
SWH pathway. One plausible hypothesis is that Crb plays an
important role in ﬁne-tuning of the SWH pathway activity
by favoring Ex function through an eﬀect on its localization,
while limiting its level (Figure 2). Collectively, these data
show that Crb is a regulator of the SWH pathway, conferring
toCrbtheabilitytocontrolproliferationandepithelialtissue
size.
In mammals, high cell density leads to a cytoplasmic
retentionofYAPthroughtheactivationoftheSWHpathway,
which thereby contributes to contact-mediated inhibition
of growth [68, 69]. This implies that a receptor sensing
cell density relays information to the SWH pathway to
limit proliferation. Similar to YAP, members of the SMAD
family, which regulate transcription downstream of TGF-β
signaling [70], are enriched in the nucleus of cells cultivated
at low density, whereas they are trapped in the cytoplasm
of epithelial cells grown at high density [71]. Interestingly,
phosphorylated YAP binds to SMAD2/3, suggesting that
phospho-YAP could contribute to the cytoplasmic retention
of these proteins. Accordingly, knockdown of LATS kinases
results in a nuclear accumulation of both YAP and SMAD2/3
along with an increase in expression of TGF-β target genes
[71]. This shows that the SWH pathway regulates TGF-
β/SMADs signaling through a YAP-dependent regulation of
SMAD localization. Strikingly, YAP binds to CRB3 com-
plex components, and knockdown of CRB3 decreases YAP
phosphorylation. Reduction of CRB3 correlates with YAP
and SMAD2/3 nuclear accumulation and potentiates TGF-
β-induced EMT [71]. This mechanism may explain how the
loss of CRB3 leads to EMT in other cell types [46]. Thus,
like Drosophila Crb, CRB3 participates in the regulation of
theSWHpathway.Inparticular,CRB3couplescelldensityto
activation of this pathway. It will be interesting to investigate
whether this functional relationship has a tumor suppressor
function in humans. One initial step would be to correlate
CRB3 expression and localization with Yki target genes’
expression in cancer tissues.
3.2.2. Control of Notch Signaling by Crb. Notch proteins are
evolutionarily conserved transmembrane receptors, which
are activated by transmembrane ligands expressed at the
surface of adjacent cells [72]. Notch-mediated short-range
intercellular communication fulﬁlls crucial roles in embry-
onic development and tissue renewal. Notch activation4 Journal of Biomedicine and Biotechnology
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Figure 2: Functional relationship linking Crb proteins to the SWH pathway. (a) In Drosophila, nuclear Yki promotes cell proliferation and
survival by modulating gene expression. Activation of the SWH pathway leads to the phosphorylation and cytoplasmic retention of Yki.
Binding to the FERM domain protein Ex also prevents the nuclear translocation of Yki. Crb restricts Yki-dependent tissue hyperplasia by
contributing to Ex localization and function. Overexpression of Crb leads to degradation of Ex, suggesting that Crb plays a crucial role in the
ﬁne-tuning of the SWH activity by activating Ex, while limiting its level. The table lists the components of the SWH pathway in Drosophila
and mammals. (b) In mammalian cells, high cell density activates the SWH pathway, which contributes to contact-mediated inhibition of
growth. Phosphorylation of YAP also results in cytoplasmic sequestration of SMAD proteins, thus limiting TGF-β responsiveness. CRB3 is
important to couple cell density information to the SWH, perhaps through a homophilic interaction, leading to the suppression of TGF-β
signaling and epithelial to mesenchymal transition.
inﬂuencescellfatespeciﬁcation,proliferation,apoptosis,and
diﬀerentiation. It is therefore not surprising that deregu-
lation of Notch signaling has profound eﬀects on tissue
homeostasis and results in human pathologies, including
many human cancers [73]. Following ligand binding, Notch
intracellular domain (NICD) is released by proteolysis. Full
proteolytic processing of NICD requires the multimeric
γ-secretase complex. Processed NICD reaches the nucleus
where it partakes in a transcription complex allowing for
expression of Notch pathway target genes [72].
In Drosophila wing epithelial discs, Notch promotes the
expression of Crb, which represses Notch activity [74]. Thus,
Notch signaling reﬁnes itself by inducing the expression of
its repressor. The function of Crb in limiting Notch signaling
is not restricted to the wing disc epithelium. Loss of Crb in
the developing eye imaginal disc results in Notch-dependentJournal of Biomedicine and Biotechnology 5
overproliferation and tissue hyperplasia [65].Severalmecha-
nismsmayexplaintheeﬀectofCrb onNotchsignaling.First,
Crb inhibits endocytosis of Notch [65], which is required for
activation of Notch signaling [75, 76]. Secondly, Crb limits
γ-secretase complex activity, thus interfering with Notch
processing [74]. Similarly, human CRB2 inhibits γ-secretase
action in cell lines and cell-free assays [77]. CRB1 and CRB3
also show a similar inhibitory eﬀect. CRB2 associates with
components of the γ-secretase complex. This interaction
dependsonCRB2transmembranedomain,whichisessential
for γ-secretase complex inhibition [77]. This suggests that
CRB2 counteracts γ-secretase-mediated proteolysis through
a direct interaction. Crb family proteins are also functionally
linked to Notch signaling in zebra ﬁsh. In this vertebrate
organism, the extracellular domain of Crb binds to Notch
and inhibits its activity in cis[78]. This mechanism involving
a direct interaction of Crb with Notch might be conserved,
as Crb-dependent Notch inhibition in ﬂies requires the
extracellular domain of Crb [65]. Finally, the Crb-dependent
regulation of Notch may depend on the ability of Crb
to activate the SWH pathway. Indeed, YAP1 stimulates
proliferation through activation of Notch signaling [58]. In
addition, the membrane localization of Notch is increased
in hpo mutant clones [79]. However, the SWH pathway,
and Notch can activate each other in Drosophila ovaries
[80, 81] .T h u s ,m o r ew o r ki sr e q u i r e da tt h i sp o i n tt oc l a r i f y
the complex functional relationship linking Crb, the SWH
pathway and Notch signaling. Overall, these studies establish
that Crb proteins share an evolutionarily conserved function
in limiting Notch signaling. Several mechanisms have been
proposed to explain how Crb family members limit Notch-
modulated cell behavior (Figure 3), but further studies are
required to clarify whether lack of CRB proteins favor tumor
growth through activation of Notch signaling.
3.2.3. Regulation of Apical Junctional Complexes by Crb
Proteins. The barrier function of epithelia relies on diﬀerent
types of junctional complexes, which maintain cohesion
between epithelial cells and seal the intercellular space.
The zonula adherens (ZA), a belt-like adherens junction,
makes prominent contribution to adhesive forces holding
epithelial cells together [82] .T h eZ Aa l s op l a y sc r u c i a lr o l e s
in tissue morphogenesis and homeostasis. The homophilic
adhesion receptor E-cadherin is a core component of the
ZA. E-cadherin indirectly links the cortical microﬁlaments
of neighboring cells through cytoplasmic adaptor proteins,
including β-catenin [82]. Drosophila Crb is required for
proper assembly of the ZA in epithelial and photoreceptor
cells [83, 84]. Moreover, Crb contributes to precisely local-
izing the ZA through apical displacement of the scaﬀold
protein Bazooka (Baz; Par3 in c. elegans and vertebrates),
which acts as a landmark to establish the ZA at the apical-
lateral border [85–88]. The capacity of Crb to promote
ZA integrity may confer to this protein the ability to
maintain epithelial tissue homeostasis. Indeed, E-cadherin
has an important tumor suppressor function, by limiting
proliferation, invasion, and metastasis [89]. Many human
tumor types show a loss of E-cadherin expression. Loss of
Crb N
N
γ-secretase
Endocytosis
Figure 3: Crb proteins control Notch-dependent tissue growth.
Crb proteins repress Notch (N) signaling in Drosophila,z e b r a
ﬁsh, and mammalian cells. Diﬀerent mechanisms account for
the Crb-dependent inhibition of Notch signaling. Drosophila Crb
and CRB2 inhibit γ-secretase activity. In addition, Crb limits
Notch endocytosis, which is important for Notch signaling. Finally,
the extracellular domain of Crb proteins binds to Notch and
counteracts its activity.
E-cadherin expression in cancer may be explained by loss
of heterozygosity, epigenetic modiﬁcation of the E-cadherin
locus, and transcriptional silencing by EMT-promoting
factors. Many mechanisms other than genetic alterations
or epigenetic modiﬁcations can interfere with E-cadherin
function. For instance, regulation of E-cadherin level at
the plasma membrane by endocytosis is important for ZA
integrity[89].Interestingly,appropriatelevelofCrbresulting
from the equilibrium between its delivery, endocytosis, and
recycling could play an important role in stabilizing E-
cadherin at the membrane, [90, 91]. However, a formal
demonstration of this hypothesis is awaited. In addition,
expression of E-cadherin is strongly repressed during EMT
[38], which could be repressed by CRB3. Thus, it would
be pertinent to investigate whether there is a correlation
between CRB proteins and E-cadherin expression in human
cancers and to better deﬁne CRB proteins function in the
regulation of ZA integrity, especially in vertebrates.
While the cohesion of epithelial cells largely depends
on the ZA, the selective permeability of epithelia relies on
tight junctions (TJs) in vertebrates and septate junctions in
invertebrates[92,93].TJssitjustapicaltotheZAandrestrict
paracellular diﬀusion. Several transmembrane proteins are
associated with TJ, including members of the claudin family,
which are core components of TJ required for their assembly,
and CRB3 [94, 95]. In the absence of CRB3, TJ integrity is
compromised [95]. Structure-function analysis revealed that
the C-terminal ERLI motif is required for the positive impact
of CRB3 on TJ organization [43, 95]. Consistent with this
observation, PALS1 and Patj, which are recruited into the
CRB3 complex through the ERLI domain, are also required
to establish functional TJ [34, 35]. Dysfunctions of TJ were
linked to cancer over recent years [94]. Overexpression of
ZO-1, a protein associated with the cytoplasmic face of
TJ, blocks proliferation in cultured epithelial cells [96].6 Journal of Biomedicine and Biotechnology
Thus, it is not surprising that ZO-1 level is decreased in
several human tumors [97, 98]. The mechanism used by
ZO-1 or other TJ proteins to maintain a normal epithelial
phenotype remains elusive. However, increasing evidence
suggests that TJ proteins have an impact on proliferation
through regulation of gene expression. For instance, ZO-1
binds to and sequesters the dual-location protein ZONAB at
TJ [96, 99]. Loss of ZO-1 or disruption of TJ releases this
protein, which can then translocate to the nucleus where
it acts as a transcription factor. ZONAB upregulates the
expression of cell cycle regulators, DNA replication factors,
and oncogenes [96, 99, 100]. Moreover, ZONAB binds to
CDK4 to favor its nuclear accumulation, thus facilitating the
G1/S transition [96]. ZO-2, a TJ-associated protein related
to ZO-1, can also regulate gene expression. ZO-2 can shuttle
in the nucleus to repress cyclin D1 expression [101]. Thus,
it is possible that CRB3 limits proliferation by maintaining
TJ integrity and sustaining TJ-dependent gene expression
regulation. However, it will be important to investigate
whether CRB3 has a direct impact on the regulation of TJ-
associated transcription factor regulating proliferation such
as ZONAB.
4. Conclusions andPerspectives
Recent studies have established that Crb/CRB proteins
regulate epithelial tissue growth by acting as transmembrane
proteins controlling intracellular signaling important for
proliferation and apoptosis. Crb/CRB proteins are linked
to many pathways through diﬀerent domains, showing a
complex function for these proteins in relaying growth-
control signals. Indeed, Crb/CRBs inhibit Notch signaling
through a direct interaction with the extracellular domain
of Notch receptor in cis,c o u n t e r a c tγ-secretase activity
using the transmembrane domain, control Ex localization
activity using the FERM domain-binding site within the
cytoplasmictail,whilepromotingTJintegritythroughtheC-
terminal ERLI amino acids. These studies therefore provide
mechanistic insights linking a cell polarity regulator to
restriction of tissue hyperplasia. One outstanding question
is whether CRB3 acts as a receptor transmitting extracellular
cues inside the cell to maintain epithelial homeostasis.
Although the extracellular domain of CRB3 is short, it may
be involved in protein-protein interaction or may bind to
lectin proteins, as it is glycosylated [22]. Identiﬁcation of
bindingpartnersfortheextracellulardomainofCRB3would
help in addressing this question. Further investigation is
required at this point to formerly establish that CRB3 is a
tumor suppressor in humans, but deciphering the molecular
mechanisms acting downstream of CRB3 seems a promising
avenue to better understand cancer biology and to identify
potential therapeutic targets.
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